Literature DB >> 36171939

Thyroidectomy and uncontrolled graves' disease - Multidisciplinary approach prevents unnecessary cancellation.

Chandra M Kumar1.   

Abstract

Entities:  

Year:  2022        PMID: 36171939      PMCID: PMC9511844          DOI: 10.4103/joacp.JOACP_177_20

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


× No keyword cloud information.
Dear Editor, Thyroidectomy is the definitive treatment for thyrotoxicosis for patients resistant to medical treatment and performed preferably when the patient is euthyroid.[1] Sometimes it may not be possible to render a patient euthyroid for various reasons leading to postponement or deferment of surgery.[2] A 35-year-old woman, was suffering from Graves’ disease, confirmed by a low thyroid-stimulating hormone (<0.005 miliunits/L), markedly elevated free thyroxine (>100 nanograms/dL), and positive thyroid receptor antibodies. Thionamide (carbimazole) therapy was started to lower the circulating thyroid hormone levels and beta-blockers added to reduce her hyper-adrenergic symptoms. She developed adverse drug effects resulting in agranulocytosis which necessitated discontinuing thionamide therapy. A multidisciplinary team consisting of an endocrinologist, endocrine surgeon, and anaesthetist was convened and a consensus view emerged for urgent total thyroidectomy. In preparation for surgery Lugol’s iodine and oral propranolol 20 mg 8 hourly administered to control tachycardia. Intravenous hydrocortisone 100 mg 8 hourly was started 1 week prior to planned operation to reduce peripheral conversion of free thyroxine to free triiodothyronine. General anaesthesia was administered with target-controlled infusion (TCI) of propofol and remifentanil with intubating dose of atracurium. Neural integrity monitor (NIM) electromyogram tracheal tube was used for intraoperative recurrent laryngeal nerve function monitoring. No further dose of atracurium was used. Anaesthesia was maintained with total intravenous anaesthesia (TIVA) using TCI devices and depth of anaesthesia was monitored with bispectral index (BIS monitor). Total thyroidectomy with parathyroid preservation was uneventful. After a brief observation in the post-anaesthesia recovery unit, she was transferred to the high dependency unit for monitoring. The postoperative course was complicated by severe hypocalcaemia (0.82 mg/dL) due to transient postsurgical hypoparathyroidism. This was confirmed by inappropriately normal parathyroid hormone levels post-surgery despite severe hypocalcaemia. Prolonged and severe stimulation of thyroid hormone is known to induce a high bone turnover state described as thyrotoxic osteodystrophy.[34] The high incidence of hypocalcaemia after thyroidectomy in thyrotoxic patients suggests that rapid loss and sudden removal of T3 and T4 hormone stimulation and inadequate parathyroid hormone response resulting in transient post-thyroidectomy hypocalcaemia. The calcium levels stabilized over the next 3 days with intravenous calcium replacement; subsequently, she was discharged with oral calcium and vitamin D supplements. Thyroidectomy may be the last option in some patients with Graves’ thyrotoxicosis refractory to medical treatment who cannot be optimized by medical treatment. A multidisciplinary team approach may help in appropriate preparation of patients prior to thyroidectomy avoiding unnecessary cancellation or postponement of surgery. Close postoperative monitoring of serum-ionized calcium is also recommended.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

Review 1.  Anaesthesia for thyroid surgery: perioperative management.

Authors:  Alessandro Bacuzzi; Gianlorenzo Dionigi; Andrea Del Bosco; Giovanni Cantone; Tommaso Sansone; Erika Di Losa; Salvatore Cuffari
Journal:  Int J Surg       Date:  2008-12-13       Impact factor: 6.071

2.  Hypocalcaemia following thyroidectomy for thyrotoxicosis.

Authors:  A C See; K C Soo
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

3.  Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis.

Authors:  W Michie; T Duncan; D W Hamer-Hodges; P D Bewsher; J M Stowers; C A Pegg; G Hems; A J Hedley
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

4.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.